Gilead Sciences reports strong Q2 results, raises full-year guidance, and sees shares rise despite higher R&D expenses and a decline in operating margin.
U.S. doubles reward for Maduro, citing 'narco-state' as Venezuela's leader remains openly in the country.
Pelosi leads national push to preserve access to gender-affirming care for transgender minors amid federal restrictions and legal battles.
Gilead Sciences reports strong Q2 results, raises full-year guidance, and sees shares rise despite higher R&D expenses and a decline in operating margin.
U.S. doubles reward for Maduro, citing 'narco-state' as Venezuela's leader remains openly in the country.
Pelosi leads national push to preserve access to gender-affirming care for transgender minors amid federal restrictions and legal battles.